Table 1.
Demographic and clinical data of COVID-19 patients.
| Patients (n = 81) | |
|---|---|
| Demographics | |
| Age, years | 45 (13) |
| Sex | |
| Male | 48 (59.3%) |
| Female | 33 (40.7%) |
| Ethnicity | |
| Chinese | 68 (84.0%) |
| Others | 13 (16.0%) |
| Comorbidities | 28 (34.6%) |
| Diabetes | 7 (8.6%) |
| Hypertension | 15 (18.5%) |
| Others | 11 (13.6%) |
| Vital signs at admission | |
| Temperature, °C | 37.7 (0.9) |
| Heart rate, beats/min | 91.4 (16.6) |
| Respiratory rate, per min | 18.4 (1.9) |
| Diastolic blood pressure, mmHg | 97.5 (2.4) |
| Systolic blood pressure, mmHg | 132.2 (18.5) |
| Oxygen saturation, % | 77.8 (15.2) |
| Laboratory findings | |
| Haemoglobin, g/dL | 13.8 (1.6) |
| Haematocrit, % | 40.8 (4.6) |
| Platelets, x 109/L | 194.8 (69.8) |
| White blood cells, x 109/L | 5.3 (3.0) |
| Lymphocytes, x 109/L | 1.2 (0.6) |
| Neutrophils, x 109/L | 4.3 (7.7) |
| Monocytes, x 109/L | 0.6 (1.1) |
| C-reactive protein (CRP), mg/L | 37.4 (55.7) |
| Creatinine, μmol/L | 75.0 (45.3) |
| Lactate dehydrogenase (LDH), U/L | 514.3 (298.4) |
| Alanine aminotransferase (ALT), U/L | 34.6 (28.1) |
| Clinical outcome (clinical severity; group) | |
| No pneumonia (0; mild) | 34 (42.0%) |
| Pneumonia, without hypoxia (1; moderate) | 28 (34.5%) |
| Pneumonia, with hypoxia (2; severe) | 19 (23.5%) |
Data represented as Mean (S•D) or n (%). COVID-19: Coronavirus Disease-19.